JPRN-UMIN000000884已完成未知
A comparison of lamivudine plus adefovir and entecavir for chronic hepatitis B patients who had not previously received a nucleoside analogue: A randomized trial - LAM plus ADV vs ETV for nucleoside naive HBV patients, a randomized trial
niversity of Tokyo Department of Gastroenterology, Faculty of Medicine0 个研究点目标入组 200 人开始时间: 2007年11月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The exclusion criteria are as follows: a previous history of a severe drug hypersensitivity against nucleoside analogues, malignancy within 5 years, severe renal disease (BUN more than 40 mg/dl or creatinine more than 2.0 mg/dl) the presence of other forms of liver disease such as auto immune hepatitis, coinfection with hepatitis C, history of liver transplantation, participation in another clinical trial, receiving prohibition medication for combination, and doctors' stop not to register to the study.
研究者
相似试验
已完成
不适用
A comparison of lamivudine plus adefovir and entecavir for chronic hepatitis B patients whose HBV DNA levels are below the level of detection by PCRJPRN-UMIN000000898niversity of Tokyo Department of Gastroenterology, Faculty of Medicine200
已完成
不适用
Efficacy of lamivudine plus adefovir therapy or adefovir add on therapy for entecavir-resistant hepatitis B patientsCertain infectious and parasitic diseasesKCT0000085Ajou University37
进行中（未招募）
不适用
A Comparative Study of Entecavir vs Adefovir Plus Lamivudine vs CombinationEntecavir plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Subjects: TheDEFINE StudyRevised Protocol 02, incorporating protocol amendment 02 (Version 2.0, date 23-Jan-2007), protocol amendment 03 (Version 4.0, date 07-Nov-2007) and Administrative Letter 01. - The DEFINE StudyEUCTR2006-000422-31-GRBristol-Myers Squibb International Corporation462
进行中（未招募）
不适用
Comparative Study of Entecavir vs Adefovir vs the Combination in Lamivudine- Refractory Chronic Hepatitis B Subjects The DEFINE Study Revised Protocol 01 - The DEFINE StudyEUCTR2006-000422-31-ITBristol-Myers Squibb International Corporation462
Unknown
3 期
Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis BChronic Hepatitis BNCT01270165Yonsei University110